Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Stagflation Looms: Why Economists Are Warning of a Rare and Painful Economic Storm April 28, 2025 Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Heliostar Delivers Strong First Quarter 2025 Results April 28, 2025